Dr. Jean-Pierre Obeid, MD

Dr. Obeid practices at Baptist Health Baptist Hospital in Miami, Florida, part of Baptist Health South Florida.

Dr. Obeid's NPI, 1770012411, was assigned on June 7, 2017. Dr. Obeid graduated from University of Miami, Miller School of Medicine in 2017. Dr. Obeid holds Florida license ME155688.

Dr. Obeid's primary practice is Baptist Health Baptist Hospital, at 8900 N Kendall Dr, Miami, FL 33176 in Miami-Dade County. The practice phone is (786) 596-1960.

Dr. Obeid's primary practice is Baptist Health Baptist Hospital in Miami, Florida, part of Baptist Health South Florida. The medical group on file is Baptist Health Medical Group Oncology. Dmand AI also links Dr. Obeid to 1 more breast imaging center, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Obeid practices, 2 sites in all. Vendor and product names are available with a free account.

Radiation oncology is Dr. Obeid's primary specialty in the NPI Registry, under taxonomy code 2085R0001X. Dr. Obeid is board certified in radiation oncology by the American Board of Radiology. Dmand AI has Dr. Obeid's licenses on file in 3 states: Florida, California and Massachusetts.

Dmand AI lists bone cancer radiation, brain cancer radiation, brain tumor radiation, breast cancer radiation, cancer radiation-upper GI, colorectal cancer radiation, head & neck cancer radiation and lung cancer radiation among the conditions Dr. Obeid treats.

CMS data shows 1,566 Medicare services from Dr. Obeid across 15 procedure codes in 2024, for 265 Medicare patients. Medicare paid $103,029 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 265 Medicare patients who saw Dr. Obeid in 2024. The largest group is 75 to 84, with 114 patients. 75% of them have cancer, and 75% have high blood pressure. 12% are also on Medicaid. Their average risk score is 1.89, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Obeid's median patient age at 67, with 49% women.

In 2024, Dr. Obeid wrote 43 Medicare Part D claims for 27 patients. 93% of them were for generic drugs. CMS names the drug for 17 of them, across 1 drug with 11 or more claims each, at $130 in total drug cost. In 2023, CMS named 40 claims across 2 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 93 out of 100 for Dr. Obeid for performance year 2024, reported as part of a group. Dr. Obeid accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Obeid as offering telehealth.

Dmand AI links 13 papers to Dr. Obeid, published from 2016 to 2022. 2017 was the busiest year, with 3. The most frequent topics are Radiation Oncology, COVID-19 and Pandemics. Dr. Obeid has published most often in Int J Radiat Oncol Biol Phys. Dr. Obeid's most frequent co-authors are Erqi Liu Pollom, Youssef Zeidan, MD, PhD and Christopher Ryan Deig, MD.

CMS Open Payments shows 14 general payments to Dr. Obeid from 8 drug and device companies from 2021 to 2025. Consulting fees make up the largest share, 95% of the total. MIM Software Inc. paid the most, $28,257.

Dmand AI lists 2 awards for Dr. Obeid, most recently Alpha Omega Alpha in 2017.

Dr. Obeid graduated from University of Miami, Miller School of Medicine in 2017.

Dr. Obeid is in network with 11 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 9. Check the plan with the practice before a visit.